Shenzhen · industrial automation · servos & humanoid joints

Inovance Technology

A leader in Chinese servo, drive and PLC motion control. It spans the robotics value chain from servos and controllers to full robots, and in 2025 launched humanoid joint-module (servo plus reducer) components. Its precision motion-control tech applies directly to humanoid joints, making it a core supplier to Chinese humanoids like UBTech.

300124.SZ Updated Jul 12, 2026 4 AI consumers· 2 recurring

Per the valuechain.wiki graph, Inovance Technology is directly linked to 1 companies (0 supply, 1 revenue relationships) and reaches 2 companies within two hops; the links are backed by 4 dated sources, 1 of them primary filings (as of 2026-07-12).

Annual return · 2026-09-04'21-5.1%'22+19.2%'23-20.9%'24+8.4%'25+24.8%YTD-20%
Money inChina robots · industrial (servos · PLC)Amount ¥45.1BUBTech RoboticsAmount ¥45.1BEV · new energy (drives)Amount ¥45.1B
Inovance TechnologyRMB 45.1bn
Money outmanufacturing & capacity expansion (undisclosed)Amount ¥45.1Bcomponents, materials & R&D (undisclosed)Amount ¥45.1B

Financials & Segments

  • Total revenue · RMB 45.1bn (FY2025 consolidated, +22%), China's industrial-automation/servo leader
  • Customer concentration · Servo+reducer joint modules; supplies UBTech.
  • Segments · Servo/drives · PLC/motion control · Humanoid joint modules

Revenue from

  • China robots · industrial (servos · PLC) High confidence· Amount ¥45.1B · Inovance FY2025 매출(+22%)
    Servos, drives and PLCs to Chinese robotics and industrial automation — the No.1 servo maker's core industrial revenue.
    Confirms EN Robotics & Automation News Published Sep 25, 2025: Inovance targets humanoid components and servo
    Confirms EN Morgan Stanley Published Jan 1, 2025: Mapping the humanoid robot value chain
  • UBTech Robotics Medium confidence· Amount ¥45.1B · Inovance FY2025 매출(+22%)
    Supplies servos and joint modules to Chinese humanoids like UBTech — a core relationship placing precision motion control in the joint, where humanoid mass production is demand.
    Confirms ZH Inovance/SZSE Published Mar 1, 2026: Inovance company/IR (SZSE 300124)
    Confirms EN Robotics & Automation News Published Sep 25, 2025: Inovance targets humanoid components and servo
    Confirms EN Morgan Stanley Published Jan 1, 2025: Mapping the humanoid robot value chain
  • EV · new energy (drives) Medium confidence· Amount ¥45.1B · Inovance FY2025 매출(+22%)
    Drives and inverters to EV/new-energy — an end-market beyond automation, but the axis exposed to 2026's Chinese EV slowdown.
    Mentions EN Analyst consensus Published Apr 1, 2026: Inovance (300124) analyst consensus — Buy, target RMB 87.5 (22 firms)
    Confirms EN Robotics & Automation News Published Sep 25, 2025: Inovance targets humanoid components and servo

Pays to

  • manufacturing & capacity expansion (undisclosed) Low confidence· Amount ¥45.1B · Inovance FY2025 매출(+22%)
    Motion-control manufacturing and capacity — capex to meet humanoid and industrial demand (undisclosed).
    Confirms EN Morgan Stanley Published Jan 1, 2025: Mapping the humanoid robot value chain
  • components, materials & R&D (undisclosed) Low confidence· Amount ¥45.1B · Inovance FY2025 매출(+22%)
    Power semis, parts and R&D — the cost axis of servo/drive performance, where in-housing parts drives margin (suppliers undisclosed).
    Confirms EN Robotics & Automation News Published Sep 25, 2025: Inovance targets humanoid components and servo

Value-chain ripple (2 tiers)

Following node-to-node links up to 2 tiers; each firm is shown once, at its nearest tier.

CompanyChain'21'22'23'24'25YTD
Foxconn (Hon Hai)lead2-5.1+2.8+7.8+80.1+26.9+19.6
UBTech Roboticslead1···-21.6+95.4-38.8
Inovance Technologynode-5.1+19.2-20.9+8.4+24.8-20

YTD as of 2026-09-04 · source: Yahoo Finance

Inovance Technology operates across Shenzhen, industrial automation, servos & humanoid joints. After +24.8% in 2025, it corrected -20% in 2026. The stock (-20%) and its demand side (avg -38.8%) are moving in step. Its precision motion-control tech applies directly to humanoid joints, making it a core supplier to Chinese humanoids like UBTech.

Analysis generated from returns as of 2026-09-04

Analyst ratings

Consensus: Buy 2 · Hold 0 · Sell 0 · Avg. target ¥91 · Price ¥59.31 (09-04) · Upside +53%

BrokerRatingTargetPublished
Goldman SachsBuy¥92.9Jul 1, 2026Report
Soochow SecuritiesBuy¥88.8Apr 28, 2026Report

← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com